Medical and pharmaceutical applications of mobile EEG (brain scanning)

Post on 29-Nov-2014

1.095 views 0 download

description

Uses of inexpensive, personal, commercially-available, and portable EEG devices for medical research. Testing of new drugs, patient-specific drug selection, monitoring of patient progress, augmentation of treatments (via neurofeedback), prediction of 'attacks' in mental illnesses (e.g. panic disorder), and better diagnoses of neurological disorders.

Transcript of Medical and pharmaceutical applications of mobile EEG (brain scanning)

04/09/2023 1

Personal Neuro Devices:Medical applications of

mobile EEG

04/09/2023 2

Electroencephalography (EEG)

04/09/2023 2

Reads brain activity

Neurofeedback therapy

Can track aspects of thought, emotion

04/09/2023

Mobile EEG

04/09/2023 3

Not bound to lab

Links to smartphone

Makes EEG monitoring available anywhere

Currently mostly for games

PND: mobile EEG software

04/09/2023 4

Mobile EEG beyond games

Treatment, diagnostics, self-monitoring

Team neuroscientists software engineers biomedical engineers business development

experts

04/09/2023 5

PND technologies: BackupBrain

Stores EEG info online

Accessible anywhere

Deeper analysis

04/09/2023 6

PND technologies: Amygdala

Backend for non-game mobile EEG software

Streamlines mobile EEG development

Algorithms, built-in GUIs, links to BackupBrain, etc.

Proof-of-concept: Transcend

Neurofeedback-based mobile meditation app

Comprehensive meditation tracking & analysis

Reads relaxation, concentration, meditation uses in-house algorithms

Introspect

EEG self-monitoring

Records mental states via EEG waveform analysis

Introspect

Example waveformslinked to mental states

Detects: (e.g.)

Mood

Anxiety

Stress

Acute cognitive functioning

Sleep quality

Concentration

Pain ‘unpleasantness’

04/09/2023 10

Introspect

Detects problem areas

Built-in neurofeedback exercises to improve specific areas

PND neurofeedback game: psych showdown

04/09/2023 11

Neurofeedback

Training to directly alter EEG output

Mindfulness-based Meditation

Effective treatment ADHD depression Anxiety etc.

PND: Pharmaceutical uses

Based on adaptations of Introspect

Introspect malleable for Research Diagnostics Treatment Etc.

PND: Pharmaceutical uses

1) New drug testing

mobile real-time drug efficacy monitoring

E.g. observe mood in brain over time

04/09/2023 14

PND: Pharmaceutical uses

2) Aid patient-specific drug selection

EEG patterns linked to disorder etiologies

Help hospital funding

04/09/2023 15

PND: Pharmaceutical uses

3) Monitor patient progress

Ensure continued symptom control

Change treatments as needed

Example mood and anxiety chart

04/09/2023 16

PND: Pharmaceutical uses

4) Augment treatments

Raise overall efficacy

Neurofeedback

04/09/2023 17

PND: Pharmaceutical uses

5) New class of as-needed meds

Alarm for impending “attack”

Preventative drug used upon alarm

PND: Pharmaceutical uses

6) Preventative medicine

Catch “slipping” mental health before disorder develops

04/09/2023 19

PND: Pharmaceutical uses

7) Diagnostics

Link day-to-day mental states to disorders

Reduce reliance on self-report

20

Thank you!

Any questions?

References• MacDonald, P. E., Rorsman, P. (2006). Oscillations, intercellular coupling, and insulin secretion in pancreatic beta

cells. PLoS Biol, 4(2): p49.• Tatum, W. O., Husain, A. M., Benbadis, S. R. (2008). Handbook of EEG Interpretation. Demos Medical Publishing.• Niedermeyer E. and da Silva F.L. (2004). Electroencephalography: Basic Principles, Clinical Applications, and Related

Fields. Lippincot Williams & Wilkins.• Rubboli, G., Parra, J., Seri, S., Takahashi, T., & Thomas, P. (2004). EEG diagnostic procedures and special investigations in

the assessment of photosensitivity. Epilepsia, 45(s1), p35-39.• Appleton, R., Macleod ,S., Martland ,T. (2008). Drug management for acute tonic-clonic convulsions including

convulsive status epilepticus in children. Cochrane Database of Systematic Reviews, 4: CD001905• Randell T. (2004). "Medical and legal considerations of brain death". Acta Anaesthesiologica Scandinavica 48 (2): 139–

144• Wijdicks EF. Determining brain death in adults. Neurology. 1995 May; 45(5): pp.1003-11• Kupfer, D. J., Foster, F. G., Coble, P., McPartland, R. J., and Ulrich, R. F. (1978). The application of EEG sleep for the

differential diagnosis of affective disorders Am J Psychiatry 1978; 135:69-74• Otto, K. A. (2008). EEG power spectrum analysis for monitoring depth of anaesthesia during experimental surgery; Lab

Anim , 42: pp. 45-61.• Sterman, M.B.; Friar, L. (1972). "Suppression of seizures in an epileptic following sensorimotor EEG feedback

training". Electroencephalogr Clin Neurophysiol 33 (1): 89–95• Basic concepts and clinical findings in the treatment of seizure disorders with EEG operant conditioning". Clin

Electroencephalogr 31 (1): 45–55.• Hammond, Corydon D. "Neurofeedback Treatment of Depression and Anxiety." Journal of Adult Development, Vol 12,

Nos. 2/3, August 2005• Gastaut, H. (1952). "Etude electrocorticographique de al reactivite des rhytmes rolandiques". Rev. Neurol 87 (2): 176–

182• Sny der et al. (2008). Blinded, multi-center val i da tion of EEG and rati ng scales in iden ti fy ing ADHD within a clin i cal sam

ple. Psy chi a try Research, 159, 346–358

References• Caat, M. T., Lorist, M. M., Bezdan, E., Roerdink, J. B., & Mauritis, N. M. (2008). High-Density EEG Coherence Analysis Using

Functional Units Applied to Mental Fatigue. Journal of Neuroscience Methods, 17, pp. 271-278.• Nuwer, M,, et al, (2005). Routine and Quantitative EEG in Mild Traumatic Brain Injury; Clinical Neurophysiology, 116.• Thatcher, R.W., Camacho, M,, Salazar, A, Linden, C., Biver, C. and Clarke, L.: Quantitative MRI of Gray-White Matter

Distribution in Traumatic Brain Injury. Journal of Neurotrauma, Volume 14, No. 1, 1-14, 1997• Thatcher, R.W., Moore, N, John, E.R., et al.: QEEG and Traumatic Brain Injury: Rebuttal of the American Academy of

Neurology 1997. A Report by the EEG and Clinical Neuroscience Society, Clinical Electroencephalography, 30(3): 94-98, 1999

• Khodayari-Rostamabad, A., Hasey, G. M., Maccrimmon, D. J., Reilly, J. P., & de Bruin, H. (2010). A pilot study to determine whether machine learning methodologies using pre-treatment electroencephalography can predict the symptomatic response to clozapine therapy. Clinical Neurophysiology, 121(12), 1998–2006

• Baskaran, A., Milev, R., & McIntyre, R. S. (2012). The neurobiology of the EEG biomarker as a predictor of treatment response in depression. Neuropharmacology, 63(4), 507–13

• Thompson, L. et al (2010). Neurofeedback outcomes in clients with Asperger’s syndrome. Applied psychophysiology and biofeedback, 35(1), 63–8

• Kouijzer, M., et al. (2009). Neurofeedback Treatment for Autism Spectrum Disorders: Scientific Found- ations and Clinical Practice. Autism Spectrum Disorders – From Genes to Environment (p. 101–122)

More available on request